ResearchHub | Open Science Community

DF

Darren Foreman

Author with expertise in Pancreatic Cancer Research and Treatment

Achievements

Open Access Advocate

Key Stats

Upvotes received:

0

Publications:

2

(100% Open Access)

Cited by:

1

h-index:

7

/

i10-index:

6

Reputation

Biology

< 1%

Chemistry

< 1%

Economics

< 1%

Show more

How is this calculated?

Publications

Elevation of the tumor marker CA19‐9 in a pancreatic cancer survivor with benign prostatic hyperplasia: A clinical case report

Steve Pendry et al.May 24, 2024

Key Clinical Message Serum carbohydrate antigen 19‐9 (CA19‐9) is used for recurrence surveillance in patients with resected pancreatic ductal adenocarcinoma (PDAC). This report describes the association of increasing CA19‐9 in a male PDAC survivor with presence of prostatic hyperplasia. Unexplained elevation of CA19‐9 in male PDAC survivors might be attributable to benign prostatic conditions.

Internal Medicine

0

Paper

Save

A Novel Machine Learning-Based Predictive Model of Clinically Significant Prostate Cancer and Online Risk Calculator

Flavio Ordones et al.Nov 1, 2024

Artificial Intelligence

0

Paper

Artificial Intelligence

Save